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Abstract
Introduction. Poland is a member of the WHO European Region where a complete eradication of measles and rubella is planned 
to be finished by 2015. Poland accounted for 99% of all reported rubella cases in 27 EU/EEA countries in 2013. It is a good time to 
evaluate whether the established Polish vaccination strategy was sufficient to reach the goal of rubella elimination in the near future. 
Aim. The aim of this study was to analyze the epidemiology of rubella in Poland when the disease outbreak took place 
in 2013, to determine the reasons of that situation and to find the solution for future rubella elimination strategies.
Material and methods. To analyze the epidemiology of rubella in Poland during the disease outbreak in 2013 the authors 
used rubella surveillance data collected by the Provincial and National Notifiable Disease Reporting System in 2004-2013. 
The information at the provincial level derived from one of the 16 provinces (Malopolska). The data on MMR vaccination 
coverage in 2003-2012 derived from the National Surveillance System. The percentages of rubella cases and vaccine coverage 
between Poland with Malopolska province were compared. 
Results. The outbreak started in late 2012 and continued through 2013, when 38548 rubella cases (incidence rate 100.1/ 
100 000) were notified. Geographically, rubella cases were reported from the entire country, with the highest incidence rate 
in Malopolska province (254.9/100 000). Only 5 cases from Malopolska and 120 in whole country were laboratory confirmed, 
the remaining 99.7% were reported solely on the basis of clinical signs. The vaccination coverage was not sufficient to protect 
the population against rubella outbreak in Poland, especially among adolescents and young adult males. 
Conclusions. The strengthening of routine immunization program and implementation of some additional vaccination 
campaigns in young adults as well as laboratory confirmation of all suspected cases are the challenges that will have to be met 
to eliminate rubella in Poland.
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coverage and by targeting susceptible population, including 
women of childbearing age. Rubella vaccine has been avail-
able since 1970s and proves highly effective. The one-dose 
single rubella vaccine (using the vaccine strain Wistar RA 
27/3) was introduced in Poland in 1988, targeting only girls 
aged 12. Earlier, since 1975 all infants had been vaccinated 
against measles only. The triple vaccine against measles, 
mumps and rubella (MMR) has been recommended instead 
of single measles vaccine since the end of 1990s (with extra 
charge). It was recommended for children at 13-15 month 
and at 7 year of life in place of mandatory vaccination against 
measles.  However less than 20% of infants were vaccinated 
with that strategy in that period of time [5]. The MMR vac-
cine, using the rubella Wistar RA 27/3 strain, was introduced 
to childhood mandatory immunization program in 2004. 
Initially this immunization program targeted infants at 13-
14 month of life. One year later, all children aged 12 years 
and older girls, who had not been vaccinated with single-
antigen rubella vaccine before, were additionally vaccinated 
with MMR. Since 2006 only MMR triple vaccine has been 
IntRoduCtIon
Rubella is usually a mild, febrile rash illness in children 
and adults, however the infection in early pregnancy can 
result in miscarriage, stillbirth or multiple birth defects, 
including congenital rubella syndrome (CRS). Congeni-
tal malformations have been reported in up to 85% of in-
fants born to women with confirmed diagnoses of rubella 
during the first trimester of pregnancy. Available evidence 
indicates that rubella is a disease that can be eradicated. 
An intermediate stage to eradicate rubella is its elimination [1]. 
The earlier suggested feasibility of rubella elimination has 
been proved in the South and North America where rubel-
la and CRS elimination was announced by Pan American 
Health Organization in 2010 [2,3].
Poland is a member of the WHO European Region where 
measles and rubella elimination is planned by 2015 [4]. 
The disease should be eliminated by using combined mea-
sles and rubella vaccines taking form of routine two dose 
vaccination programs, by achieving and maintaining high 
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available in Poland and the two-dose MMR (the first dose 
administered at 13-14 months and the second at the age of 
10) vaccine policy was executed as a mandatory vaccination 
(at no charge). Since 2010 adolescents born between 1997 
and 2003, vaccinated with the first dose of MMR at the age 
of 10 or 12, were gradually revaccinated with the second 
dose. According to the current vaccination schedule, all ado-
lescents up to 16th year of life should be vaccinated with two 
doses of MMR by the end of 2013. The recommended MMR 
vaccine policy in adulthood was treated as a voluntary option 
for unvaccinated women of childbearing age [6]. Nowadays, 
nearly 10 years after MMR vaccine implementation to man-
datory immunization program, it is a good time to evaluate 
whether the established Polish vaccination strategy was suffi-
cient to reach the goal of rubella elimination in the near future. 
AIM
The aim of this study was to analyze the epidemiology 
of rubella in Poland when the disease outbreak took place 
in 2013, to determine the reasons of that situation and to find 
the solution for future rubella elimination strategies.
MAtERIAL And MEtHodS
This is a descriptive epidemiological study. The analysis 
was conducted using rubella surveillance data collected by 
the Provincial and National Notifiable Disease Reporting 
System in 2004-2013. 
In Poland there are three levels of Surveillance System. 
Physicians report each rubella case to the local health depart-
ments, providing demographic information, International 
Classification of Diseases (ICD-10) code, case classification 
and vaccination status. They use the European Union (EU) 
case definitions for rubella and congenital rubella syndrome 
(CRS) [7]. Every two weeks, local health departments report 
the number of cases notified in their area to the provincial 
health departments that aggregate data, which is then be-
ing forwarded to the National Institute of Public Health – 
National Institute of Hygiene. Every month, provincial 
health departments prepare reports with more detailed data 
including the number of cases by age group, sex, vaccina-
tion status and case classification. Physicians also report to the 
same Surveillance System annual data on the vaccination cov-
erage among children and adolescents (based on their year of 
birth) included in their general practice. The information used 
in our analysis, on both the cases and the vaccination cover-
age, derived from the national and provincial level (Malopol-
ska province) [5,8]. 
RESuLtS
When MMR vaccination was introduced to childhood 
immunization program in 2004, rubella was endemic in 
Poland, with periodic epidemics occurring approximately 
every 5 years and seasonal increases in incidence at the end 
of winter and spring. The vaccination strategy gradually in-
fluenced epidemiological situation of rubella – the incidence 
rate of endemic and epidemic periods was lower compared 
to pre-vaccination era. This optimistic trend  significantly 
changed in 2013 when the number of cases in Poland sharply 
increased to 38 548 (incidence rate 100.1/100 000). Geo-
graphically, rubella cases were reported from the entire coun-
try with the highest incidence rate in Malopolska province 
(254.9/100 000) (Figure 1) and the lowest in Lower Silesian 
province (18.1/100 000). Two more provinces, Wielkopolska 
and Lubuskie province, had rubella incidence rates over 
200/100 000. Mean incidence rate, calculated from all 16 
provinces, equaled 99.9±71.2 per 100 000. The number of 
cases began to slowly increase in 2012, the rise in cases con-
tinued by 2013, but at the beginning of 2014 the incidence rate 
in Poland and  Malopolska province was significantly lower 
compared to the same period of 2013. In endemic years, 
mostly infants and children were affected by the disease, 
with similar number of cases in boys and girls. The situation 
started to change in 2012, when of 743 cases in Malopolska 
province, males accounted for 88.8%, of which 87.7% were 
aged over 15 years (Table 1a). Per 664 reported rubella cases 
with known vaccination status in 2012, 88.4% occurred 
in individuals who had not received rubella vaccine. In 2013 
that was 89.4% (3910 per 4375 cases with known vaccination 
status). Similar distribution of cases according to age groups 
was reported on national level in 2012 and 2013 (Table 1b). 
When  rubella incidence rate increased more than 11 times 
in 2013 compared to the previous year, the outbreak ex-
panded to older age groups, especially males. In Malopolska 
province in 2013, 86.7% of 8557 cases were persons aged 
over 15 years, while on national level it was 82.6%. Among 
rubella cases last year in Malopolska, vaccination history 
was unknown in 48.5% of individuals. Regarding the cases 
with known vaccination status, nearly half of females had 
been vaccinated (with one or two doses of rubella-containing 
vaccine) but the majority of males had been unvaccinated. 
According to available data on national level, the cases had 
unknown vaccination status less often compared to Malopol-
ska province (27.0% vs. 48.5%). However, the percentage of 
unvaccinated cases on national level was similar compared 
to the studied province (83.6% vs. 89.3%). In 2013, only five 
cases reported from Malopolska (0.06%) were laboratory 
confirmed, while in the whole country there were 120 such 
cases (0.3%) (initially these cases were suspected as mea-
sles). The rest of them was clinically diagnosed. Only the 
measles suspected cases are assigned to be laboratory con-
firmed. In Poland rubella cases are recognized only on the 
basis of clinical symptoms. Two CRS cases were reported 
nationwide in 2013, none of them occurred in Malopolska 
province.
 
FIGuRE 1. Rubella incidence per 100 000 population in Poland 
and Malopolska Province in 2004-2013.
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Rubella population immunity is measured by adminis-
trative MMR coverage. After vaccine introduction to man-
datory strategy, the MMR coverage in youngest children 
significantly increased and remained on stable level over 
the last years (Figure 2). MMR coverage was above 83% 
at 2nd year of life, 97% and 98% at 3rd and 4th year of life, 
respectively. The MMR coverage was accounted among 
the infants who were under control of the surveillance sys-
tem. About 5% of children and adolescents were not includ-
ed in the surveillance system and their vaccination status 
was unknown. This problem exists within other provinces 
in Poland on similar level (Figure 3). At the beginning of 
rubella outbreak at the end of 2012, the MMR coverage 
in the population included to mandatory vaccination strat-
egy did not significantly differ in Malopolska province 
compared to average coverage for Poland (Table 2). At the 
regional level, the second MMR-dose-coverage was lower 
in ado-lescents aged 14-15 years compared to the natio-
nal level (71.3%-72.9%, and 77.0%-79.2%, respectively). 
The women of childbearing age (>15 years) were mostly 
vaccinated with one-dose of single rubella vaccine as the 
girls were aged 12 years. The young males (born before 
1997) were not assigned to be vaccinated against rubella. 
tABLE 1A. Percentage of rubella cases by age, sex and vaccination status in Malopolska province in 2009-2013.
 
2009 2010 2011 2012 2013
n % n % n % n % n %
 total 389 100 307 100 181 100 743 100 8557 100
 males 251 64.5 159 51.8 77 42.5 660 88.8 7663 89.6
 females 138 35.5 148 48.2 104 57.5 83 11.2 894 10.4
age groups           
males 0 17 6.8 10 6.3 8 10.4 6 0.9 44 0.6
 1-4 44 17.5 55 34.6 19 24.7 31 4.7 169 2.2
 5-9 77 30.7 62 39.0 31 40.3 31 4.7 273 3.6
 10-14 47 18.7 27 17.0 18 23.4 13 2.0 225 2.9
 15-19 50 19.9 2 1.3 0 0.0 415 62.9 4119 53.8
 20-24 10 4.0 0 0.0 1 1.3 115 17.4 1934 25.2
 25-29 2 0.8 2 1.3 0 0.0 28 4.2 532 6.9
 ≥30 4 1.6 1 0.6 0 0.0 21 3.2 367 4.8
females 0 5 3.6 11 7.4 13 12.5 7 8.4 33 3.7
 1-4 40 29.0 47 31.8 33 31.7 20 24.1 137 15.3
 5-9 61 44.2 64 43.2 42 40.4 19 22.9 185 20.7
 10-14 11 8.0 11 7.4 6 5.8 6 7.2 76 8.5
 15-19 7 5.1 4 2.7 2 1.9 3 3.6 91 10.2
 20-24 5 3.6 2 1.4 2 1.9 6 7.2 50 5.6
 25-29 1 0.7 4 2.7 0 0.0 5 6.0 49 5.5
 ≥30 8 5.8 5 3.4 6 5.8 17 20.5 273 30.5
vaccination           
males  1 dose 61 33.2 79 69.9 36 65.5 41 6.8 226 5.7
 2 doses 2 1.1 10 8.8 10 18.2 4 0.7 42 1.1
 not vaccinated 121 65.8 24 21.2 9 16.4 559 92.5 3681 93.2
 missing data 67  46  22  56  3714  
females 1 dose 63 60.0 68 74.7 41 60.3 26 43.3 173 40.6
 2 doses 0 - 1 1.1 10 14.7 6 10.0 24 5.6
 not vaccinated 42 40.0 22 24.2 17 25.0 28 46.7 229 53.0
 missing data 33  57  36  23  468  
 
FIGuRE 2. the MMR vaccine coverage of Polish infants in 2003-2012 
(in relation to children included in vaccination reports).
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dISCuSSIon
Initially, CRS control activities focused on vaccinating 
girls and women, what decreased rubella virus transmis-
sion but resulted in large proportion of susceptible males. 
A large population susceptible to rubella infection is at 
high risk of outbreak and virus transmission to unimmu-
nized pregnant women [9]. This scenario took place in 2013 
in Poland. Fortunately, despite 38548 rubella cases reported 
during last year, only two CRS cases occurred at the same 
period of time. In last 10 years up to 2013, no CRS or the 
only one case per year was notified. It is too early to assess 
the real impact of rubella outbreak on the number of CRS 
cases because any affected infants would be born 9 months 
after the 2013 outbreak. Up to the end of October 2014, 
no CRS case was reported [10].  
In 1988, Poland established a goal to prevent CRS, 
and implemented single rubella vaccine in national immu-
nization program, targeting girls aged 12 years. The MMR 
vaccine was introduced in 2004 to eliminate measles and ru-
bella, targeting infants aged 12 months and in 2005, children 
tABLE 1B. Percentage of rubella cases by age, sex and vaccination status in Poland in 2009-2013.
 
2009 2010 2011 2012 2013
n % n % n % n % n %
 total 7587 100 4197 100 4290 100 6263 100 38548 100
 males 4897 64.5 2417 57.6 2379 55.5 4777 76.3 33796 87.7
 females 2690 35.5 1780 42.4 1911 44.5 1486 23.7 4752 12.3
age groups
males 0 195 4.0 188 7.8 127 5.3 154 3.2 300 0.9
 1-4 725 14.8 633 26.2 621 26.1 498 10.4 1186 3.5
 5-9 1498 30.6 814 33.7 812 34.1 556 11.6 1537 4.5
 10-14 1055 21.5 364 15.1 287 12.1 174 3.6 765 2.3
 15-19 1171 23.9 325 13.4 411 17.3 2617 54.8 19403 57.4
 20-24 124 2.5 43 1.8 63 2.6 560 11.7 7206 21.3
 25-29 49 1.0 20 0.8 28 1.2 133 2.8 1964 5.8
 ≥30 80 1.6 30 1.2 30 1.3 85 1.8 1435 4.2
females 0 189 7.0 155 8.7 185 9.7 181 12.2 279 6.0
 1-4 637 23.7 517 29.0 570 29.8 495 33.3 971 20.9
 5-9 1284 47.7 736 41.3 730 38.2 443 29.8 1243 26.7
 10-14 278 10.3 186 10.4 230 12.0 100 6.7 412 8.9
 15-19 70 2.6 47 2.6 55 2.9 57 3.8 391 8.4
 20-24 41 1.5 18 1.0 24 1.3 28 1.9 178 3.8
 25-29 44 1.6 53 3.0 31 1.6 33 2.2 151 3.2
 ≥30 147 5.5 68 3.8 86 4.5 149 10.0 1027 22.1
vaccination
males  1 dose 1515 34.9 1183 56.9 1315 62.6 884 25.9 2133 8.6
 2 doses 60 1.4 61 2.9 144 6.9 64 1.9 357 1.4
 not vaccinated 2765 63.7 836 40.2 643 30.6 2466 72.2 22182 89.9
 missing data 557 337 277 1363 9124
females 1 dose 1312 55.7 1034 68.3 1206 72.1 804 67.8 1872 53.5
 2 doses 53 2.2 42 2.8 100 6.0 49 4.1 246 7.0
 not vaccinated 992 42.1 437 28.9 366 21.9 333 28.1 1380 39.5
 missing data 333 267 239 300 1254
 
FIGuRE 3. Percentage of persons up to 20 years missed in vaccination 
reports per population, by province in 2012.
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campaigns. Young males in Poland have not been timely 
identified as a potential gap in the population immunity. 
The ongoing outbreak has not significantly changed the vac-
cination policy in Poland. The only change from this year 
(2014) were MMR recommendations for young adult males 
unvaccinated with MMR according to mandatory schedule 
or if the time since first vaccine dose was longer than 10 years. 
Earlier the same recommendation referred  to young females 
only. These voluntary option recommendations for males are 
not sufficiently strong to bring significant results. Further-
more, the rubella outbreak revealed that too low MMR cov-
erage in youngest children did not protect this cohort against 
the rubella virus infection. Among rubella cases in children 
up to 10th year of life there were many unvaccinated cases 
and cases with unknown vaccination status. It serves as an 
evidence of a gap in vaccination surveillance system in such 
important cohort like the youngest children. About 5% of the 
population  up to 20 years of age was not under vaccina-
tion coverage surveillance. This makes a very important gap 
in immunization not only for rubella elimination strategy, 
but even more for measles. In recent years 30-60 measles 
cases were reported per year in Poland. The number of cases 
increased up to 88 in 2013. Only 55% of measles cases were 
confirmed by laboratory tests. About 15% of suspected mea-
sles cases were confirmed as  rubella cases [4]. On the other 
hand, it is more likely that many measles cases with atypical 
course of disease were reported as rubella cases, which was 
diagnosed on the basis of clinical symptoms only. Having 
very low incidence rate of measles in the last decade, the ma-
jority of physicians have difficulties in diagnosing measles 
clinically, especially because of the fact, that the cases can 
currently present mild or atypical symptoms and are shifted 
to the older age groups. At this stage of rubella epidemiologi-
cal situation in Poland, physicians should not have problems 
to diagnose rubella clinically. The lack of laboratory confir-
mation of rubella cases is not so important for sensitivity of 
surveillance, on the stage when there is so high incidence of 
this disease compared to measles in recent years. However, 
the lack of laboratory confirmation of rubella can negatively 
influence measles control. Owing to relatively huge rubella 
outbreak, we have uncertain epidemiological situation with 
respect to measles which should be close to the target of 
elimination. The Polish experience is an evidence support-
ing the implementation of elimination strategies with respect 
to measles and rubella concurrently [14,15]. 
The rubella outbreak in Poland has proved that our popula-
tion has not been protected against rubella. According to the 
WHO strategy for measles and rubella elimination  coverage, 
≥95% of the general population with first and second doses 
of measles and rubella-containing vaccines at the national 
and subnational administrative levels should be achieved 
[16]. We have to pay special attention to increase the first-
dose MMR coverage among the infants by 24 months of age 
provided through the routine program. We have been achiev-
ing the required vaccination coverage among infants by 36 
month of age, with nearly one year of delay compared to 
the requirements. Furthermore, MMR coverage was counted 
for infants whose medical records were under surveillance 
system. It is necessary to include under surveillance about 
5% of children and adolescents who pertain to the gaps 
tABLE 2. the MMR vaccine coverage by year of birth (1997-2011) 
at the end of 2012.
persons 
born in
unvaccinated 1-dose MMR 2-dose MMR
Po
la
nd
M
al
op
ol
sk
a
Po
la
nd
M
al
op
ol
sk
a
Po
la
nd
M
al
op
ol
sk
a
2011 16.4% 16.6% 83.6% 83.4% NA NA
2010 2.1% 2.7% 97.9% 97.3% NA NA
2009 1.1% 1.5% 98.9% 98.5% NA NA
2008 0.7% 0.9% 99.3% 99.1% NA NA
2007 0.5% 0.6% 99.5% 99.4% NA NA
2006 0.4% 0.5% 99.6% 99.5% NA NA
2005 0.3% 0.4% 99.7% 99.6% NA NA
2004 0.2% 0.3% 99.8% 99.7% NA NA
2003 0.5% 0.3% 22.9% 15.9% 76.6% 83.8%
2002 1.1% 1.2% 28.1% 24.5% 70.8% 74.4%
2001 0.8% 1.0% 32.1% 30.2% 67.1% 68.7%
2000 0.6% 0.7% 31.0% 30.8% 68.4% 68.5%
1999 0.5% 0.6% 20.0% 19.6% 79.6% 79.8%
1998 0.7% 0.7% 20.1% 26.3% 79.2% 72.9%
1997 0.6% 0.8% 22.4% 28.0% 77.0% 71.3%
19961 34.7% 32.9% 36.5% 41.1% 28.7% 25.9%
19952 43.4% 38.2% 34.9% 40.9% 21.7% 20.9%
19943 49.0% 47.4% 33.6% 40.9% 17.4% 11.7%
19934 81.2% 84.0% 13.5% 12.8% 5.3% 3.2%
19925 98.0% 97.3% 0.5% 1.6% 1.6% 1.1%
NA – not applicable because 2nd vaccine dose is administrated at the age of 10; 
1at the end of 2009; 2at the end of 2008; 3at the end of 2007; 4at the end of 2006; 
5at the end of 2003; 
aged 10 years also. This vaccination policy was manda-
tory for all the children included. Furthermore, the MMR 
was recommended to women before pregnancy who were 
not vaccinated against rubella or the vaccine was adminis-
tered to them more than 10 years before pregnancy. Accord-
ing to current immunization program in Poland, children 
and adolescents up to 17th  year of life should be vaccinated 
with 2-dose MMR vaccine [6]. The routine vaccinations 
have not been supplemented by any additional campaigns 
[4]. This vaccination strategy led us to the huge outbreak, 
when nearly 99% of rubella cases in Europe were report-
ed from Poland [11]. It was the year when, according to 
Measles and Rubella Elimination Plan for WHO European 
Region, we should have been close to elimination of both 
of these diseases [1].
The MMR vaccination policy established in Poland is 
an evidence of a failed strategy. It should serve as an exam-
ple for other countries which are planning their vaccination 
policies to eliminate rubella. A large proportion of suscepti-
ble persons should not be left over because, sooner or later, 
the outbreak will occur among this population. Such types of 
outbreaks like in Poland took place also in the other countries 
and emphasize that vaccination policy should ensure high 
levels of immunity to all cohorts born since the introduc-
tion of rubella vaccine [12,13]. Vaccination policy should be 
conducted either through the routine vaccinations or mass 
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with unknown vaccination status. The ongoing outbreak 
has been giving the unprotected cohorts  an opportunity to 
develop natural immunity against rubella but with the risk 
of disease complications and CRS cases occurrence. Even-
tually, the rubella outbreak has increased the immunity of 
many individuals, but the proportion of the population which 
remained susceptible is not known. Regardless rubella in-
fection history, the unvaccinated young population should 
be included to the additional vaccination campaigns. How-
ever, achieving high MMR coverage in infants will be the 
most difficult because of decreasing public acceptance of 
vaccination in Poland. The anti-vaccine organizations that 
portray themselves as official resources for credible data 
on vaccines, continue to provide flawed or biased informa-
tion about MMR and its association with autism or other 
developmental delays [17,18]. This problem, especially re-
lated to low acceptance of MMR, has been observed in many 
countries for recent years [19]. The MMR mandatory strat-
egy has not improved vaccination coverage to the adequate 
level (>=95%). Despite the rubella herd immunity threshold 
required lower rubella vaccine coverage in population (80%) 
[20] compared to measles threshold (95%) [16], the higher 
coverage is necessary to achieve both diseases elimination 
using the triple vaccine. According to Polish law, there are 
financial penalties for parents who avoid vaccinating their 
children without adequate contraindications. However, this 
penalty system does not work efficiently enough. Without 
better acceptance of MMR vaccination, Poland will not be 
able to meet the goal of measles and rubella elimination 
[21,22]. Additional studies are necessary to identify the other 
reasons why, in the routine program, not all of the eligible 
children are being vaccinated in a timely manner.
Immunization coverage should be monitored both on the 
national and regional level, since the local authorities are 
more at a chance of identifying any potential gaps in popula-
tion immunity. There is an important question, why rubella 
incidence rate in Malopolska province was 2.5-fold higher 
in 2013, compared to average incidence in Poland. It seems not 
to be connected neither with demographic nor social factors. 
The five provinces with highest rubella incidence rates 
(>100/100 000) are not more densely populated or economi-
cally worse from the others. It could be attributed to differ-
ing MMR immunization coverage standards in Polish prov-
inces. On the other hand, the rubella surveillance sensitivity 
in Malopolska province may be higher compared to the other 
provinces. One rule usually exists: the greater disease severi-
ty, the better surveillance sensitivity. Rubella is rather treated 
not as a severe disease with self-limiting course that can be 
one of the reasons of  low surveillance sensitivity in some 
areas [19]. The closer to the state of rubella elimination, 
the higher a sensitivity of cases surveillance will be required, 
but at the current stage the most important is the strengthen-
ing of MMR vaccination strategy in Poland. 
ConCLuSIon
All things considered, inspite of the substantial progress 
that has been made toward a complete rubella elimination 
between 2004 and 2012, a resurgence of the disease hap-
pened in 2013. The large outbreak occurred mostly among 
adolescents and adult males. The strengthening of routine 
immunization program and implementation of some ad-
ditional vaccination campaigns in young adults as well 
as laboratory confirmation of all suspected cases are the 
challenges that will have to be met in order to eliminate 
rubella in Poland. 
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